[1] |
LIU Xiumei, GUO Qianqian, FANG Yuan, CHEN Nan, QI Qi.
Pharmaceutical care of patients with antithrombotic therapy after transjugular intrahepatic portal shunt
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 556-560.
|
[2] |
WU Yuanzhu, LIU Jun, YANG Kui, PENG Jing, LUAN Jiajie, WEI Jun, ZHANG Dafa, SONG Shuai, YUAN Xiaolong, WANG Zhongfang, ZHANG Nianbao, XIE Dan, JIANG Peng, FAN Jie.
Distribution of CYP2C9*3 and VKORC1-1639G>A gene polymorphism in Anhui Han population and their influence on the stable dose of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 652-659.
|
[3] |
LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang.
Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273.
|
[4] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
[5] |
ZHAI Yu, YANG Jin.
Effects of dietary vitamin K on the stability of warfarin anticoagulation therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 709-715.
|
[6] |
WANG Shiqi, HU Huawen, CHEN Xiaomin, WANG Jian, YE Honghua.
Effects of different intensities of warfarin on patients with coronary atherosclerotic heart disease complicated with atrial fibrillation: a comparative study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1410-1414.
|
[7] |
YANG Rui, XU Haisha, ZHANG Zanling, QU Jian, LI Juan, PENG Shiqi, DAI Yuxin, QU Qiang.
Effect of drug interaction on anticoagulant strength of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1426-1431.
|
[8] |
LI Haigang, FAN Rong, MA Ning, TANG Jing, LIAO Hongchun, ZHENG Xiahui.
Research progress on pharmacokinetics factors of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1292-1298.
|
[9] |
LI Lin, ZHANG WEI, SHEN Chen-lin, ZHANG Ping, HUANG Xiao-hui.
Study of drug interaction between aspirin and warfarin in situ intestinal absorption model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 486-492.
|
[10] |
HU Jing, ZHU Jun-rong, YU Feng.
Efficacy and safety of warfarin dosage algorithms in clinical application:A Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 296-303.
|
[11] |
YIN Shuo, YU Yue, GUO Xing-lei, LIU Gao-feng.
Effects of traditional Chinese medicine on the role of warfarin and the mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 327-334.
|
[12] |
LIU Jun, XU Hang.
Evaluation of warfarin anticoagulant management by clinic pharmacists on patients with cardiac valve surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1021-1024.
|
[13] |
HU Jing, ZHU Junrong, YU Feng.
Dosing algorithms for warfarin individualized therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 591-596.
|
[14] |
LIU Jun, LUAN Jia-jie, XU Wen-ke, ZHU Yan-hong, WANG Wei-ping, ZHANG Da-fa.
Study on warfarin individual dosage model based on clinical factors and gene in Chinese Han population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 284-290.
|
[15] |
XIONG Qin-mei, HONG Kui.
Survey on anticoagulant therapy in pregnant women with cardiovascular disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 223-227.
|